Rezvan Esmaeili

1.3k total citations
47 papers, 981 citations indexed

About

Rezvan Esmaeili is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Rezvan Esmaeili has authored 47 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Cancer Research and 10 papers in Organic Chemistry. Recurrent topics in Rezvan Esmaeili's work include Synthesis and biological activity (8 papers), Cancer-related molecular mechanisms research (8 papers) and Circular RNAs in diseases (8 papers). Rezvan Esmaeili is often cited by papers focused on Synthesis and biological activity (8 papers), Cancer-related molecular mechanisms research (8 papers) and Circular RNAs in diseases (8 papers). Rezvan Esmaeili collaborates with scholars based in Iran, Spain and United States. Rezvan Esmaeili's co-authors include Keivan Majidzadeh‐A, Zahra Eslami‐S, Sina Halvaei, Alireza Foroumadi, Setareh Moghimi, Nasrin Abdoli, Loghman Firoozpour, Adileh Ayati, Leila Farahmand and Mahsa Toolabi and has published in prestigious journals such as Scientific Reports, Expert Systems with Applications and Journal of Cellular Physiology.

In The Last Decade

Rezvan Esmaeili

46 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rezvan Esmaeili Iran 17 532 268 212 152 104 47 981
Sifan Yu China 18 519 1.0× 145 0.5× 150 0.7× 230 1.5× 149 1.4× 56 878
Gong Cheng China 18 656 1.2× 317 1.2× 228 1.1× 156 1.0× 126 1.2× 34 1.1k
Peiwen Yang China 17 503 0.9× 248 0.9× 115 0.5× 196 1.3× 110 1.1× 75 1.0k
Alexios J. Aletras Greece 18 427 0.8× 209 0.8× 78 0.4× 216 1.4× 101 1.0× 35 1.0k
Wenhao Guo China 20 500 0.9× 246 0.9× 55 0.3× 237 1.6× 166 1.6× 30 1.0k
Santina Quarta Italy 24 661 1.2× 355 1.3× 64 0.3× 288 1.9× 112 1.1× 64 1.5k
Lilia Matei Romania 16 363 0.7× 215 0.8× 129 0.6× 182 1.2× 169 1.6× 44 854
Peiqi Wang China 18 333 0.6× 81 0.3× 196 0.9× 100 0.7× 54 0.5× 52 867
Bin Kang China 16 551 1.0× 280 1.0× 48 0.2× 182 1.2× 89 0.9× 39 842

Countries citing papers authored by Rezvan Esmaeili

Since Specialization
Citations

This map shows the geographic impact of Rezvan Esmaeili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rezvan Esmaeili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rezvan Esmaeili more than expected).

Fields of papers citing papers by Rezvan Esmaeili

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rezvan Esmaeili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rezvan Esmaeili. The network helps show where Rezvan Esmaeili may publish in the future.

Co-authorship network of co-authors of Rezvan Esmaeili

This figure shows the co-authorship network connecting the top 25 collaborators of Rezvan Esmaeili. A scholar is included among the top collaborators of Rezvan Esmaeili based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rezvan Esmaeili. Rezvan Esmaeili is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Esmaeili, Rezvan, et al.. (2024). Performance enhancement of deep neural network using fusional data assimilation and divide-and-conquer approach; case study: earthquake magnitude calculation. Neural Computing and Applications. 36(27). 16899–16910. 1 indexed citations
2.
Najafi, Safa, et al.. (2023). Evaluation of PIK3CA Gene Mutations in Breast Cancer Patients Treated by Trastuzumab. Archives of Breast Cancer. 248–255. 1 indexed citations
3.
Peytam, Fariba, Loghman Firoozpour, Setareh Moghimi, et al.. (2023). Imidazo[1,2-a]quinazolines as novel, potent EGFR-TK inhibitors: Design, synthesis, bioactivity evaluation, and in silico studies. Bioorganic Chemistry. 133. 106383–106383. 10 indexed citations
4.
Esmaeili, Rezvan, et al.. (2023). Dysregulation of miR-577, miR-505-3p, miR-3682-3p, and miR-4661 in Breast Cancer Patients Based on Estrogen Receptor Status. Galen Medical Journal. 12. 1 indexed citations
5.
Mohajeri, Afshan, et al.. (2023). A coumarin-based fluorescent chemosensor as a Sn indicator and a fluorescent cellular imaging agent. RSC Advances. 13(15). 9811–9823. 3 indexed citations
6.
Moghimi, Setareh, Fariba Peytam, Roham Foroumadi, et al.. (2022). Design, synthesis and evaluation of novel tetrahydropyridothienopyrimidin-ureas as cytotoxic and anti-angiogenic agents. Scientific Reports. 12(1). 9683–9683. 8 indexed citations
7.
Esmaeili, Rezvan, et al.. (2021). Mesenchymal Stem Cells Pretreatment With Stromal-Derived Factor-1 Alpha Augments Cardiac Function and Angiogenesis in Infarcted Myocardium. The American Journal of the Medical Sciences. 361(6). 765–775. 10 indexed citations
8.
Gorgin, Saeid, et al.. (2021). Gene co-expression network analysis reveals immune cell infiltration as a favorable prognostic marker in non-uterine leiomyosarcoma. Scientific Reports. 11(1). 2339–2339. 18 indexed citations
9.
Majidzadeh‐A, Keivan, et al.. (2021). A comprehensive reference for BRCA1/2 genes pathogenic variants in Iran: published, unpublished and novel. Familial Cancer. 21(2). 137–142. 1 indexed citations
10.
11.
Eslami‐S, Zahra, et al.. (2020). Microbiome and Breast Cancer: New Role for an Ancient Population. Frontiers in Oncology. 10. 120–120. 112 indexed citations
12.
Firoozpour, Loghman, et al.. (2020). Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis. European Journal of Medicinal Chemistry. 209. 112942–112942. 47 indexed citations
13.
Naghib, Seyed Morteza, et al.. (2019). Biocomposites based on hydroxyapatite matrix reinforced with nanostructured monticellite (CaMgSiO4) for biomedical application: Synthesis, characterization, and biological studies. Materials Science and Engineering C. 105. 109912–109912. 31 indexed citations
14.
Toolabi, Mahsa, Setareh Moghimi, Somayeh Salarinejad, et al.. (2019). 6-Cinnamoyl-4-arylaminothienopyrimidines as highly potent cytotoxic agents: Design, synthesis and structure-activity relationship studies. European Journal of Medicinal Chemistry. 185. 111786–111786. 39 indexed citations
15.
Ayati, Adileh, Rezvan Esmaeili, Setareh Moghimi, et al.. (2018). Synthesis and biological evaluation of 4-amino-5-cinnamoylthiazoles as chalcone-like anticancer agents. European Journal of Medicinal Chemistry. 145. 404–412. 39 indexed citations
16.
Majidzadeh‐A, Keivan, et al.. (2018). Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets. Critical Reviews in Oncology/Hematology. 131. 102–109. 65 indexed citations
17.
Esmaeili, Rezvan, Nasrin Abdoli, Mohamadreza Neishaboury, et al.. (2018). Unique CD44 intronic SNP is associated with tumor grade in breast cancer: a case control study and in silico analysis. Cancer Cell International. 18(1). 28–28. 5 indexed citations
18.
Ayati, Adileh, Setareh Moghimi, Rezvan Esmaeili, et al.. (2018). Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety. European Journal of Medicinal Chemistry. 155. 483–491. 41 indexed citations
19.
Halvaei, Sina, et al.. (2017). Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer. Molecular Therapy — Nucleic Acids. 10. 131–141. 150 indexed citations
20.
Majidzadeh‐A, Keivan, et al.. (2012). Tamoxifen Resistance and CYP2D6 Copy Numbers in Breast Cancer Patients. Asian Pacific Journal of Cancer Prevention. 13(12). 6101–6104. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sifan Yu Breakdown of academic impact, for papers by Gong Cheng Breakdown of academic impact, for papers by Peiwen Yang Breakdown of academic impact, for papers by Alexios J. Aletras Breakdown of academic impact, for papers by Wenhao Guo Breakdown of academic impact, for papers by Santina Quarta Breakdown of academic impact, for papers by Lilia Matei Breakdown of academic impact, for papers by Peiqi Wang Breakdown of academic impact, for papers by Bin Kang
Rankless by CCL
2026